Skip to content

The prevalence of non-fatal overdose among people who inject drugs: a multi-stage systematic review and meta-analysis

Research output: Contribution to journalArticle

Original languageEnglish
JournalInternational Journal of Drug Policy
Early online date24 Jul 2019
DOIs
DateAccepted/In press - 16 Jul 2019
DateE-pub ahead of print (current) - 24 Jul 2019

Abstract

Background: People who inject drugs (PWID) are at an elevated risk of fatal overdose in the first year after experiencing a non-fatal event. Such non-fatal events may also result in overdose-related sequelae, ranging from physical injury to paralysis. Given variation in drug markets and treatment availability across countries and regions, we may see similar variations in non-fatal overdose prevalence. Monitoring non-fatal overdose prevalence among PWID is essential for informing treatment intervention efforts, and thus our review aims to estimate the global, regional, and national prevalence of non-fatal overdose, and determine characteristics associated with experiencing such an event.

Methods: We conducted a systematic review and meta-analyses to estimate country, regional, and global estimates of recent and lifetime non-fatal overdose prevalence among PWID. Using meta-regression analyses we also determined associations between sample characteristics and non-fatal overdose prevalence.

Results: An estimated 3.2 (1.8-5.2) million PWID have experienced at least one overdose in the previous year. Among PWID, 20.5% (15.0-26.1%) and 41.5% (34.6-48.4%) had experienced a non-fatal event in the previous 12 months and lifetime respectively. Frequent injecting was strongly associated with PWID reporting recent and lifetime non-fatal overdose. Estimates of recent non-fatal overdose were particularly high in Asia and North America.

Conclusion: Around one in five PWID are at an elevated risk of fatally overdosing every year, however there is substantial geographical variation. In countries with higher rates of non-fatal overdose there is need to introduce or mainstream overdose prevention strategies such as opioid agonist treatment and naloxone administration training programs.

    Research areas

  • drug-related mortality, injecting behavior, population size, opioid overdose, people who inject drugs, non-fatal overdose

Documents

Documents

  • Full-text PDF (accepted author manuscript)

    Rights statement: This is the accepted author manuscript (AAM). The final published version (version of record) is available online via Elseveir at https://doi.org/10.1016/j.drugpo.2019.07.030 . Please refer to any applicable terms of use of the publisher.

    Accepted author manuscript, 731 KB, PDF document

    Embargo ends: 24/07/20

    Request copy

    Licence: CC BY-NC-ND

DOI

View research connections

Related faculties, schools or groups